Folate Receptor-Beta Expression as a Diagnostic Target in Human & Rodent Nonalcoholic Steatohepatitis

INTRODUCTION: Nonalcoholic steatohepatitis (NASH) afflicts 20–36% of individuals with nonalcoholic fatty liver disease (NAFLD). A lipotoxic hepatic environment, altered innate immune signaling and inflammation are defining features of progression to NASH. Activated resident liver macrophages express...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Toxicol Appl Pharmacol
Auteurs principaux: Lake, April D., Hardwick, Rhiannon N., Leamon, Christopher P., Low, Philip S., Cherrington, Nathan J.
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487882/
https://ncbi.nlm.nih.gov/pubmed/30794826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.taap.2019.02.009
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires